|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 235/34 | |
| A61K 31/165 | |||
| A61P 9/12 | |||
| A61P 13/12 |
| (11) | Number of the document | 3046901 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14845373.1 |
| Date of filing the European patent application | 2014-09-17 | |
| (97) | Date of publication of the European application | 2016-07-27 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2014/000923 |
| Date | 2014-09-17 |
| (87) | Number | WO 2015/039173 |
| Date | 2015-03-26 |
| (30) | Number | Date | Country code |
| 2013903573 | 2013-09-17 | AU |
| (72) |
DUGGAN, Karen Annette, AU
|
| (73) |
Vectus Biosystems Limited,
3-11 Primrose Avenue, Rosebery, NSW 2018,
AU
|
| (54) | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS |
| COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS |